Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Space Exploration Techn CorpCL A | 2,606 | 3,699 | +1,093 | $445.3K | $558.0K | 20.04% | +$112.6K |
| New Fortress Energy IncPFD SER A MAND | 0 | 1,214 | +1,214 | $0 | $485.6K | 17.44% | +$485.6K |
| Berkshire Hathaway Inc DelCL B | 754 | 839 | +85 | $377.1K | $417.7K | 15.00% | +$40.5K |
| Tesla, Inc.(TSLA) | 0 | 829 | +829 | $0 | $294.3K | 10.57% | +$294.3K |
| Vanguard Index FdsS P 500 ETF SHS | 339 | 378 | +39 | $233.1K | $264.7K | 9.51% | +$31.6K |
| Alphabet Inc.CL A(GOOG) | 691 | 769 | +78 | $246.9K | $264.6K | 9.50% | +$17.7K |
| Blackstone Inc.(BX) | 1,597 | 1,780 | +183 | $188.2K | $199.5K | 7.17% | +$11.3K |
| Kyverna Therapeutics Inc | 12,347 | 12,347 | 0 | $110.0K | $84.0K | 3.02% | -$26.1K |
| Lexeo Therapeutics Inc | 16,962 | 16,962 | 0 | $79.0K | $57.3K | 2.06% | -$21.6K |
| Inhibikase Therapeutics Inc | 28,453 | 27,775 | -678 | $57.8K | $57.1K | 2.05% | -$681 |
| X4 Pharmaceuticals Inc | 15,557 | 13,534 | -2,023 | $72.7K | $39.2K | 1.41% | -$33.4K |
| Sab Biotherapeutics Inc | 0 | 10,372 | +10,372 | $0 | $32.9K | 1.18% | +$32.9K |
| Alx Oncology Hldgs Inc | 20,946 | 20,946 | 0 | $43.4K | $29.1K | 1.05% | -$14.2K |